SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
January 16, 1997
---------------------------------------------------
Date of Report (date of earliest event reported)
CHESAPEAKE BIOLOGICAL LABORATORIES, INC.
--------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Maryland 1-12748 52-1176514
(State or other (Commission File (IRS Employer
jurisdiction of Number) Identification
Incorporation) Number)
1111 South Paca Street
Baltimore, Maryland 21230
(Address of principal executive offices)
410-843-5000
------------------------------------------------
(Registrant's telephone number, including area code)
Item 5: Other Events
Chesapeake Biological Laboratories, Inc. (the Registrant) has relocated
it's Corporate Office to 1111 South Paca Street, Baltimore, MD. 21230. The
Registrant acquired the 70,000 square foot building in November 1996 (see Form
8-K filed 11/21/96). In addition to corporate offices, the facility will
provide warehouse space and is being renovated and equipped as a cGMP commercial
production facility. This location is in addition to the Registrant's existing
experimental products facility also located in Baltimore.
The Registrant has appointed Mr. Thomas P. Rice as a member of the Board of
Directors. In 1996, Mr. Rice founded Columbia Investments, LLC to make
selective investments primarily in the Health Care industry. Mr. Rice had been
Executive Vice President, Chief Operating and Financial Officer and a member of
the Board of Directors of Circa Pharmaceuticals. He was a key individual in the
turn-around of the company which resulted in significant increase in shareholder
value prior to the merger of Circa with Watson Pharmaceutical. Mr. Rice had
been Vice President of Administration and Finance of Pharmakinetics
Laboratories. He was a member of the management team which returned the company
to profitability in 1985. Mr. Rice is a CPA who was an Audit Manager with
Deloitte & Touche, in Baltimore. He has an M.S. Finance from Loyola College
of Maryland.